The PMA phorbol ester tumor promoter increases canonical Wnt signaling via macropinocytosis.

Wnt signaling cancer biology colorectal cancer developmental biology lysosomes macropinocytosis xenopus β-catenin

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
30 10 2023
Historique:
medline: 31 10 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: epublish

Résumé

Activation of the Wnt pathway lies at the core of many human cancers. Wnt and macropinocytosis are often active in the same processes, and understanding how Wnt signaling and membrane trafficking cooperate should improve our understanding of embryonic development and cancer. Here, we show that a macropinocytosis activator, the tumor promoter phorbol 12-myristate 13-acetate (PMA), enhances Wnt signaling. Experiments using the

Identifiants

pubmed: 37902809
doi: 10.7554/eLife.89141
pii: 89141
pmc: PMC10615368
doi:
pii:

Substances chimiques

Carcinogens 0
Glycogen Synthase Kinase 3 EC 2.7.11.26
Phorbol Esters 0
Esters 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016042
Pays : United States
Organisme : NIH HHS
ID : P20CA016042
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023, Tejeda-Munoz, Azbazdar et al.

Déclaration de conflit d'intérêts

NT, YA, JM, GB, AD, RA, NO, ED No competing interests declared

Références

Mol Cell Biol. 2002 Apr;22(7):2099-110
pubmed: 11884598
Cell. 2010 Dec 23;143(7):1136-48
pubmed: 21183076
Genomics. 2000 Aug 15;68(1):1-12
pubmed: 10950921
Subcell Biochem. 2022;98:169-187
pubmed: 35378708
Science. 1998 Jan 23;279(5350):509-14
pubmed: 9438836
Sci Rep. 2013;3:2385
pubmed: 23924974
Nature. 2013 May 30;497(7451):633-7
pubmed: 23665962
Nat Rev Mol Cell Biol. 2004 Nov;5(11):920-31
pubmed: 15520811
Dev Cell. 2016 Sep 26;38(6):643-55
pubmed: 27676437
Genes Cancer. 2012 Feb;3(2):102-16
pubmed: 23050043
Cell. 1989 Sep 22;58(6):1075-84
pubmed: 2673541
Cell. 1996 Oct 18;87(2):159-70
pubmed: 8861899
Arch Toxicol. 2013 May;87(5):783-98
pubmed: 23266722
iScience. 2023 Sep 28;26(10):108075
pubmed: 37860772
Nature. 2019 Dec;576(7787):477-481
pubmed: 31827278
Mol Carcinog. 2005 Apr;42(4):213-21
pubmed: 15765534
Subcell Biochem. 2022;98:15-40
pubmed: 35378701
Oncogene. 2006 Dec 4;25(57):7531-7
pubmed: 17143297
J Biol Chem. 1979 May 25;254(10):3692-5
pubmed: 438153
J Cancer Res Clin Oncol. 2010 May;136(5):771-8
pubmed: 19915865
Elife. 2023 Oct 30;12:
pubmed: 37902809
Nat Rev Cancer. 2005 Oct;5(10):786-95
pubmed: 16175178
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
J Biol Chem. 2009 Jun 12;284(24):16400-16408
pubmed: 19366680
Oncotarget. 2017 Mar 28;8(13):21806-21817
pubmed: 28423521
Dev Cell. 2009 Jul;17(1):9-26
pubmed: 19619488
Cell. 2008 Apr 18;133(2):340-53
pubmed: 18423204
Nature. 1988 Aug 4;334(6181):438-40
pubmed: 2900469
Nat Rev Mol Cell Biol. 2001 Nov;2(11):793-805
pubmed: 11715046
J Exp Med. 1941 Feb 28;73(3):365-90
pubmed: 19871084
Cytoskeleton (Hoboken). 2021 Jun;78(6):303-311
pubmed: 34028199
J Cell Biol. 1979 Oct;83(1):82-90
pubmed: 315944
Nat Cell Biol. 2019 Feb;21(2):133-142
pubmed: 30602725
Cell Cycle. 2007 Jan 1;6(1):60-4
pubmed: 17245112
Proc Natl Acad Sci U S A. 2019 May 21;116(21):10402-10411
pubmed: 31061124
Mol Cell. 2014 May 22;54(4):663-74
pubmed: 24837680
Front Physiol. 2014 Sep 30;5:374
pubmed: 25324782
Sci Signal. 2012 Apr 10;5(219):ra30
pubmed: 22494971
Nat Protoc. 2014 Jan;9(1):182-92
pubmed: 24385148
J Cell Sci. 2004 Jan 26;117(Pt 3):427-39
pubmed: 14679305
Cancer Res. 2018 Aug 15;78(16):4658-4670
pubmed: 29871936
Biochim Biophys Acta. 2009 Apr;1793(4):746-54
pubmed: 18948147
iScience. 2022 Mar 19;25(4):104123
pubmed: 35402867
J Biol Chem. 1992 Aug 25;267(24):16878-82
pubmed: 1324914
Cancer Res. 1976 Dec;36(12):4562-9
pubmed: 1000501
Mol Cell. 2014 Feb 6;53(3):444-57
pubmed: 24412065
Nat Rev Mol Cell Biol. 2012 Dec;13(12):767-79
pubmed: 23151663
J Cell Biol. 2003 Apr 14;161(1):33-9
pubmed: 12695497
J Cell Biol. 1997 Sep 8;138(5):1139-47
pubmed: 9281590
J Cell Sci. 2015 Nov 1;128(21):3933-46
pubmed: 26403202
Trends Cell Biol. 2019 Jan;29(1):44-65
pubmed: 30220580
Sci Rep. 2020 Dec 9;10(1):21555
pubmed: 33299006
J Biol Chem. 1998 Aug 7;273(32):20121-7
pubmed: 9685355
Differentiation. 2014 Jul;88(1):17-26
pubmed: 24798204
Cell Mol Life Sci. 2018 Apr;75(7):1227-1239
pubmed: 29119228
J Biol Chem. 2013 Nov 8;288(45):32731-32741
pubmed: 24072707
J Cell Biol. 2010 Feb 22;188(4):547-63
pubmed: 20156964
J Cell Sci. 1989 Sep;94 ( Pt 1):135-42
pubmed: 2613767
Cell Rep. 2020 Jul 28;32(4):107973
pubmed: 32726636
Int J Mol Sci. 2022 Feb 02;23(3):
pubmed: 35163650
Nat Rev Cancer. 2005 Nov;5(11):886-97
pubmed: 16239905
Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):E7522-E7531
pubmed: 30038030
Nature. 1984 Apr 19-25;308(5961):693-8
pubmed: 6232463
Cancer Res. 2005 Apr 15;65(8):2993-5
pubmed: 15833821
Proc Natl Acad Sci U S A. 2022 Apr 26;119(17):e2201008119
pubmed: 35446621
Nature. 1986 Jul 24-30;322(6077):371-3
pubmed: 19140288
Methods Mol Biol. 2008;468:99-110
pubmed: 19099249
J Biochem. 2002 Oct;132(4):509-11
pubmed: 12359062
Drug Resist Updat. 2016 Jan;24:23-33
pubmed: 26830313
Science. 1986 Sep 5;233(4768):1061-8
pubmed: 3090687
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679
Oncogene. 2001 May 17;20(22):2844-53
pubmed: 11420696
Annu Rev Cell Dev Biol. 2021 Oct 6;37:369-389
pubmed: 34196570

Auteurs

Nydia Tejeda-Munoz (N)

Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.
Department of Oncology Science, Health Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, United States.

Yagmur Azbazdar (Y)

Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.

Julia Monka (J)

Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.

Grace Binder (G)

Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.

Alex Dayrit (A)

Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.

Raul Ayala (R)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.

Neil O'Brien (N)

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.

Edward M De Robertis (EM)

Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH